FIPAPER

Finance News and Analysis

Cidara Therapeutics shares surge 30% after reacquiring flu treatment

Shares of Cidara Therapeutics rose sharply after the company announced a reshuffling of its portfolio of drug candidates.

Leave a Reply

Your email address will not be published. Required fields are marked *